The purpose of this survey is to identify the main problems in the supply of medicines in small markets, as well as the likely causes of the said problems and the solutions and existing best practices to address them, from the perspective of economic operators.
For the purpose of this project, small markets (among EU and EAA countries) which are facing problems in terms of sufficient availability and that could result in risks of public health are the following: Cyprus, Estonia, Iceland, Latvia, Lithuania, Malta and Slovenia. This does not exclude to discuss relevant experiences and lessons from other countries worldwide.
We would like you to focus on the problems which are attributable to the small size of the market (in terms of number of population and potential patients) rather than on those that are caused by low income and financial constraints.
Take also into account that you may also save your survey at anytime while completing it and finish the remaining questions at a later time.
You can print your answers at the end of the survey.
Please do not hesitate to contact us if you have any problem
Jaime Espin and Joan Rovira (EASP)
EMINet
